Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia.
Blood Adv
; 6(1): 148-151, 2022 01 11.
Article
in English
| MEDLINE | ID: covidwho-1455908
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Leukemia, Lymphocytic, Chronic, B-Cell
/
COVID-19
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Blood Adv
Year:
2022
Document Type:
Article
Affiliation country:
Bloodadvances.2021005998
Similar
MEDLINE
...
LILACS
LIS